Gail V Matthews

10PUBLICATIONS
92CO-AUTHORS
Epidemiological modellingGene and molecular therapyInfectious diseasesPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 08, 2026
Modeling predicts shortening of DAA treatment duration to 5 weeks in individuals with recent or chronic infection with HCV RNA negativity at day 7 on treatment.

|Apr 29, 2026
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk.

|Apr 22, 2026
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial.

|Feb 20, 2026
New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort study.

Jiahui Qian, Sandrine Stepien, Allen Cheng

|Jan 20, 2026
Evaluation of fingerstick blood point-of-care testing of hepatitis B DNA for enhanced hepatitis B treatment decision making: a diagnostic accuracy study.

Behzad Hajarizadeh, Jacob George, Miriam T Levy

|Jan 03, 2026
Regional Variations of Rates and Determinants of Drug Resistance Mutations in People Failing First-line Therapy for HIV-1: A Substudy from the D2EFT Phase 3b/4 Clinical Trial.

Billal Musah Obeng, Jolie Hutchinson, Ansari Shaik

Pageof 2

Frequent Collaborators

3 joint publications

Marianne Martinello

1 joint publications

Billal Musah Obeng

1 joint publications

Ploenchan Chetchotisakd

1 joint publications

Wahyu Nawang Wulan